Achieved Fourth-Quarter and Full-Year Records for Aggregates Revenues, Gross Profit and Margin Double-Digit Improvement in Full-Year Aggregates Unit Profitability Specialties Business Delivers Record Fourth-Quarter and Full-Year Revenues and Gross Profit Company Provides 2026 Guidance RALEIGH, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) — Martin Marietta Materials, Inc. (NYSE: MLM) (“Martin Marietta” or the “Company”), a leading national supplier of aggregates and heavy building materials, today reported results for the fourth quarter and year ended December 31, 2025. Fourth-Quarter and Full-Year Highlights(Financial highlights are for continuing operations, unless otherwise noted)  Quarter Ended December 31,   Year Ended December 31,(in millions, unless otherwise noted) 2025   2024 % Change   2025   2024 % ChangeRevenues2 $ 1,534     $ 1,412   9 %   $ 6,150     $ 5,662   9 %Gross...

Q4 2025 Financial Highlights Q4 revenue of $1.6 billion decreased 8% year-over-year and 10% on an organic basis Total revenue growth of 11% and 8% on an organic basis excluding confidential contract Net income of $56 million increased 3% year-over-year, a fourth quarter record Record adjusted EBITDA of $153 million increased 5%; adjusted EBITDA margin of 9.6% Cash flow from operations increased 32% to $168 million Book-to-bill ratio of 0.9x and continued streak of TTM book-to-bill ratio of 1.0x or greater in every quarter since IPOFiscal Year 2025 HighlightsFY25 revenue of $6.4 billion, decreased 6% year-over-year and 9% on an organic basis Total revenue growth of 12% and 8% on an organic basis excluding confidential contract Record net income of $241 million increased 3% Adjusted EBITDA of $609 million increased 1%; adjusted EBITDA...

— Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— –Company to host conference call and webcast today at 8:00 a.m. ET– MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. “The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for patients to ONLY lose fat, while preserving lean mass and physical function and increasing bone mineral density for the highest quality...

Announces Board of Director Changes TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) — (TSX: CGX) – Today, Cineplex Inc. (“Cineplex” or the “Company”) released its financial results for the three months and year ended December 31, 2025. Unless otherwise specified, all amounts contained in this news release are in Canadian dollars. 2025 Highlights:Generated $91.6 million in Adjusted EBITDAaL compared to $89.9 million in the prior year Reported net loss of $36.9 million, an improvement of $67.3 million relative to the prior year net loss of $104.2 million Set annual records for Box Office Per Patron (“BPP”) at $13.29 and Concession Per Patron (“CPP”) at $9.72 International film product contributed 11.2% of total box office revenues, the highest share in Cineplex’s history Premium experiences accounted for 43.2% of total box office...

Fourth Quarter 2025 Financial Results and HighlightsRecord revenue of $80.2 million, an increase of 10% year–over–year Cloud ARR of $95.2 million, an increase of 23% year-over-year Total ARR of $251.0 million, an increase of 11% year-over-year Record non-GAAP diluted EPS of $0.32 vs. $0.27 in Q4 2024; GAAP diluted EPS of $0.13 vs. $0.06 in Q4 2024Full Year 2025 Financial Results and HighlightsRecord revenue of $301.9 million, an increase of 10% year-over-year Record non-GAAP diluted EPS of $1.15 vs. $0.87 in 2024; GAAP diluted EPS of $0.45 vs. $0.14 in 2024TEL AVIV, Israel, Feb. 11, 2026 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, today announced its consolidated financial results for the fourth quarter and full year...

Data center opportunities and assumed recovery in power outage environment support expectations for strong sales growth in 2026 WAUKESHA, Wis., Feb. 11, 2026 (GLOBE NEWSWIRE) — Generac Holdings Inc. (NYSE: GNRC) (“Generac” or the “Company”), a leading global designer and manufacturer of energy technology solutions and other power products, today reported financial results for its fourth quarter and full-year ended December 31, 2025 and initiated its outlook for the full-year 2026. Fourth Quarter 2025 HighlightsNet sales decreased 12% to $1.09 billion during the fourth quarter of 2025 as compared to $1.23 billion in the prior year fourth quarter. Acquisitions and foreign currency had a slight favorable impact of 1% during the quarter.Residential product sales decreased approximately 23% to $572 million as compared to $743 million...

CHESTERBROOK, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement technologies, today announced its results for its fiscal 2025 fourth quarter and twelve fiscal months ended December 31, 2025. Fourth Quarter Highlights:Revenues of $80.6 million increased 10.9% from a year ago Gross profit margin was 36.8%, as compared to 38.2% a year ago Adjusted gross profit margin* was 37.0%, as compared to 38.3% a year ago Operating margin was 1.3%, as compared to 0.3% reported a year ago Adjusted operating margin* was 2.3%, as compared to 0.8% reported a year ago Diluted net loss per share was $0.14, as compared to diluted net earnings per share of $ 0.06 reported a year ago Adjusted diluted net earnings per share* were $ 0.07, as compared to $ 0.03 reported a year ago Adjusted...

OP Mortgage BankFinancial Statements BulletinStock Exchange Release 11 February 2026 at 10.00 EET OP Mortgage Bank: Financial Statements Bulletin for 1 January‒31 December 2025 OP Mortgage Bank is the covered bond issuing entity of OP Pohjola. Together with OP Corporate Bank plc, its role is to raise funding for OP Pohjola from money and capital markets. Financial standing Bonds issued by OP Mortgage Bank totalled EUR 14,800 million (14,800)* at the end of December. All funds received from the bonds have been intermediated in their entirety to 54 OP cooperative banks in the form of intermediary loans. OP Mortgage Bank’s covered bonds after 8 July 2022 are issued under the Euro Medium Term Covered Bond (Premium) programme (EMTCB), pursuant to the Finnish Act on Mortgage Credit Banks and Covered Bonds (151/2022). The collateral is...

OP Corporate Bank plcFinancial Statements BulletinStock Exchange Release 11 February 2026 at 9.00 am EET OP Corporate Bank plc’s Financial Statements Bulletin 1 January–31 December 2025OP Corporate Bank’s operating profit increased by 18% to EUR 559 million (473). Total income grew by 8% to EUR 833 million (773). Net interest income grew by 9% to EUR 576 million (529). Investment income totalled EUR 131 million (136). Net commissions and fees, EUR 75 million (75), were at the previous year’s level. Other operating income increased by 54% to EUR 51 million (33). Impairment loss on receivables reversed came to EUR 32 million. A year ago, impairment loss on receivables totalled EUR 1 million.  Operating expenses increased to EUR 306 million (298). The cost/income ratio improved to 37% (39). The loan portfolio grew by 2.8%...

OP PohjolaFinancial Statements BulletinStock Exchange Release 11 February 2026 9.00 am EET OP Pohjola’s Financial Statements Bulletin 1 January–31 December 2025: Another strong year for OP Pohjola – operating profit EUR 2,269 million Operating profit was EUR 2,269 million (2,486). Operating profit fell by 9% or EUR 217 million year on year. The fourth-quarter operating profit increased to EUR 554 million (538). Net interest income decreased by 12% to EUR 2,372 million (2,694). Insurance service result increased by 23% to EUR 236 million (192) and net commissions and fees decreased by 1% to EUR 812 million (818). Income from customer business, that is, net interest income, insurance service result and net commissions and fees, decreased by a total of 8% to EUR 3,419 million (3,703). Impairment loss on receivables reversed were EUR...